HBBMHeparin-Binding Brain Mitogen (biochemistry)
HBBMHome Based Business Marketing
References in periodicals archive ?
In study HBBM, pomaglumetad methionil did not separate from placebo in the primary efficacy endpoint in either the overall or predefined genetic subpopulation (based on the Positive and Negative Syndrome Scale, PANSS) at the two doses investigated (40 mg and 80 mg BID).
Lilly plans an additional Phase II study, Study HBBM, which if positive, would validate the HBBD proof-of-concept trial results.